Long duration dual antiplatelet treatment increases bleeding

Long duration dual antiplatelet treatment increases bleeding

(HealthDay)—Routine use of dual antiplatelet therapy (DAPT) beyond six months after second generation drug-eluting stent (DES) implantation yields mixed clinical results, according to a review published in the October issue of Cardiovascular Therapeutics.

Elsayed Abo-salem, M.D., from the University of Cincinnati, and colleagues conducted a systematic literature search to identify (RCTs) comparing the continued use of DAPT with shorter duration of DAPT (aspirin alone) for variable durations beyond three months after DES implantation.

The researchers identified 10 RCTs with 32,136 subjects randomized to continued use of DAPT versus aspirin alone for variable durations after three months of DES implantation. The studies were not significant heterogeneously. Longer DAPT resulted in a significant reduction in (P < 0.01) and myocardial infarction (P < 0.01), and a significant increase in (P < 0.01), compared to shorter DAPT. Cardiac deaths or stroke did not differ by DAPT length. With shorter DAPT, all-cause deaths were slightly lower, compared to longer DAPT (odds ratio, 0.8; P = 0.04).

"DAPT continued beyond six months after second generation DES implantation decreases stent thrombosis and , but increases major bleeding and all-causes mortality compared to shorter DAPT (aspirin alone)," the authors write.


Explore further

Review: Short vs. long duration dual antiplatelet Tx after stent

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Long duration dual antiplatelet treatment increases bleeding (2015, October 1) retrieved 20 September 2019 from https://medicalxpress.com/news/2015-10-duration-dual-antiplatelet-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
6 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more